Axcelis Technologies, Inc.

ACLS · NASDAQ

Axcelis has a focused ion-implant franchise, a sizable installed-base service layer, strong cash and investment liquidity, and Veeco optionality. The hard part is that power and mature-node digestion have pulled revenue down, backlog is lower, export controls matter, and the next leg needs memory strength to become orders instead of just commentary.

Follow Add to Watchlist Ask Question

NASDAQ ACLS Coverage Bootstrap Semiconductors Capital Equipment Ion Implantation

Latest ReportMay 13, 2026Axcelis: the implant specialist waiting for memory to rescue a power-chip hangoverView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->

Admin-only preview

Valuation is limited to admins for now.

The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.